Pancreatic cancer
Conditions
Interventions
None listed
Sponsors
Department of Gastroenterological surgery 2, Hokkaido University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Pancreatic cancer patients who were diagnosed as R, BR-PV, or BR-A of the resectability classification in the General Rules for the study of Pancreatic cancer (the 7th edition) from Japan pancreatic society. 2. Patients who have not requested refusal by the research subject or by a person who is considered to represent the will and interests of the research subject. 3. 20 years or older.
Exclusion criteria
Exclusion criteria: 1. Patients who do not meet the above inclusion criteria 2. Patients with insufficient clinical data 3. Patients deemed inappropriate as research subjects by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Study 1: To examine biological Borderline Resectable (BR) patients in anatomical Resectable (R) patients of pancreatic cancer Study 2: Effect of changes in CA19-9 levels after preoperative treatment on recurrence and survival Study 3: Evaluation of the Usefulness of serum DUPAN-2 for CA19-9 Non-secretors with Pancreatic Cancer Study 4: An Exploratory study of optimal preoperative treatment for patients with borderline resectable (BR-A) pancreatic cancer Study 5: An Exploratory study of Risk Factors for Perioperative Complications related to Preoperative Therapy Study 6: Analysis of the significance of reticular pattern around superior mesenteric artery in computed tomography of R/BR pancreatic cancer and the effect of preoperative Therapy Study 7: Relationship between ABO blood type and survival outcome after pancreatectomy for pancreatic cancer Study 8: Significance of metastasectomy in patients with recurrent pancreatic cancer after pancreatectomy | — |
Countries
Japan
Contacts
Public ContactKimitaka Tanaka
Hokkaido University Hospital Department of Gastroenterological surgery 2
Outcome results
None listed